Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA541429
Max Phase: Preclinical
Molecular Formula: C6H10ClNO6
Molecular Weight: 191.14
Molecule Type: Small molecule
Associated Items:
ID: ALA541429
Max Phase: Preclinical
Molecular Formula: C6H10ClNO6
Molecular Weight: 191.14
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.NC(C(=O)O)C(CC(=O)O)C(=O)O
Standard InChI: InChI=1S/C6H9NO6.ClH/c7-4(6(12)13)2(5(10)11)1-3(8)9;/h2,4H,1,7H2,(H,8,9)(H,10,11)(H,12,13);1H
Standard InChI Key: BUZKWVDCICYKJC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 191.14 | Molecular Weight (Monoisotopic): 191.0430 | AlogP: -1.43 | #Rotatable Bonds: 5 |
Polar Surface Area: 137.92 | Molecular Species: ZWITTERION | HBA: 4 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 1.52 | CX Basic pKa: 9.68 | CX LogP: -3.84 | CX LogD: -8.45 |
Aromatic Rings: 0 | Heavy Atoms: 13 | QED Weighted: 0.42 | Np Likeness Score: 0.90 |
1. Beck J, Vercheval L, Bebrone C, Herteg-Fernea A, Lassaux P, Marchand-Brynaert J.. (2009) Discovery of novel lipophilic inhibitors of OXA-10 enzyme (class D beta-lactamase) by screening amino analogs and homologs of citrate and isocitrate., 19 (13): [PMID:19467869] [10.1016/j.bmcl.2009.04.149] |
Source(1):